Moreover, ISG20 improved the immune capacity in the tumor environment by promoting tumor-induced immune response and immune cell infiltration.[31] Another study also suggested that ISG20 expression was inversely associated with survival in glioma patients.[14] In this study, our results were consistent with these conclusions. This evidence concerns the gene ISG20 and central nervous system cancer.